Science Explorer Back to mapMap
Discussion
Researcher · Marinus Pharmaceuticals (United States) · United States

Alex A. Aimetti

Alex A. Aimetti publishes mostly in Psychiatry and Mental health, Genetics and Molecular Biology, on topics such as Epilepsy research and treatment, Genetics and Neurodevelopmental Disorders and Chemical Synthesis and Analysis.

ORCID 0009-0000-8854-1773 OpenAlex
World rank
#733,303
of 7,710,434 ranked researchers
Rank in United States
#246,867
of 1,627,098
Works
31
Citations
3.2k
Citations per work
103.2
h-index
18
i10-index 20Top 31% in Psychiatry and Mental health
Alex A. Aimetti

What does Alex A. Aimetti research?

Alex A. Aimetti's work is mostly in Medicine (21%), Biochemistry, Genetics and Molecular Biology (16%), Materials Science (7%).

Everything else: 17 works · 55.3% of their workHealth Sciences: 7 works · 21.2% of their workMedicine: 7 works · 21.2% of their workPsychiatry and Mental health: 3 works · 9.4% of their workSurgery: 2 works · 7.1% of their workPathology and Forensic Medicine: 1 works · 4.7% of their workLife Sciences: 5 works · 16.4% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 16.4% of their workGenetics: 3 works · 8.2% of their workMolecular Biology: 3 works · 8.2% of their workPhysical Sciences: 2 works · 7.1% of their workMaterials Science: 2 works · 7.1% of their workBiomaterials: 2 works · 7.1% of their workTHEIR WORKAlex A. Aimetti31works
Life Sciences16%Physical Sciences7%Health Sciences21%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1755.3%
    1. Medicine721.2%
    1. Biochemistry, Genetics and Molecular Biology516.4%
    1. Materials Science27.1%
  1. 1Psychiatry and Mental health9% of their works
  2. 2Genetics8% of their works
  3. 3Molecular Biology8% of their works
  4. 4Biomaterials7% of their works
  5. 5Surgery7% of their works
  6. 6Pathology and Forensic Medicine5% of their works

Research topics

Which keywords describe Alex A. Aimetti's research?

The keywords of their largest research topics: Inflammation, Epilepsy, Seizures, Drug Delivery, Drug Discovery, Spinal Cord Injury, Fragile X Syndrome and Rett Syndrome.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Inflammation102 topics
  2. Epilepsy71 topic
  3. Seizures71 topic
  4. Drug Delivery62 topics
  5. Drug Discovery62 topics
  6. Spinal Cord Injury62 topics
  7. Fragile X Syndrome51 topic
  8. Rett Syndrome51 topic
  9. BDNF31 topic
  10. Biomedical Applications31 topic
  11. Chitosan31 topic
  12. Click Chemistry31 topic
  13. Copper-Catalyzed Cycloaddition31 topic
  14. Epidemiology31 topic
  15. Foldamers31 topic
  16. Hydrogels31 topic
  17. Nanoparticles31 topic
  18. Neurological Classification31 topic
  19. Neurotrophins31 topic
  20. Peptide Synthesis31 topic

Where does Alex A. Aimetti work?

Alex A. Aimetti's main affiliation in the publication record is Marinus Pharmaceuticals (United States), United States.

How many publications and citations does Alex A. Aimetti have?

OpenAlex counts 31 works and 3,199 citations for Alex A. Aimetti, an h-index of 18, ranking #733,303 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Alex A. Aimetti. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.